| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 2 |
| NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: E9ADF1
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.748 |
| CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.653 |
| CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.657 |
| CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.785 |
| CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.657 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.667 |
| DOC_PP1_RVXF_1 | 31 | 38 | PF00149 | 0.634 |
| DOC_PP4_FxxP_1 | 49 | 52 | PF00568 | 0.736 |
| DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.652 |
| LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.671 |
| LIG_FHA_2 | 14 | 20 | PF00498 | 0.672 |
| LIG_LIR_Gen_1 | 9 | 18 | PF02991 | 0.767 |
| LIG_LIR_Nem_3 | 9 | 14 | PF02991 | 0.755 |
| LIG_Pex14_2 | 45 | 49 | PF04695 | 0.704 |
| LIG_REV1ctd_RIR_1 | 84 | 92 | PF16727 | 0.781 |
| MOD_CK1_1 | 58 | 64 | PF00069 | 0.669 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.735 |
| MOD_N-GLC_2 | 34 | 36 | PF02516 | 0.738 |
| MOD_NEK2_1 | 2 | 7 | PF00069 | 0.639 |
| MOD_NEK2_1 | 37 | 42 | PF00069 | 0.588 |
| MOD_NEK2_1 | 55 | 60 | PF00069 | 0.546 |
| MOD_PKA_2 | 29 | 35 | PF00069 | 0.778 |
| TRG_ER_diArg_1 | 73 | 75 | PF00400 | 0.659 |
| TRG_NLS_MonoExtC_3 | 20 | 25 | PF00514 | 0.695 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| E9AHG0 | Leishmania infantum | 84% | 96% |